Benzinga | Aug 7, 2020 06:16AM EDT

Assertio Therapeutics Q2 EPS $(0.35) Misses $(0.03) Estimate, Sales $20.62M Miss $25.33M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.03) by 1066.67 percent. This is a 66.67 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $20.62 million which missed the analyst consensus estimate of $25.33 million by 18.61 percent. This is a 63.96 percent decrease over sales of $57.20 million the same period last year.